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Abstract
The idea of using facemasks for source control is not new. The concept has been
published since 1918 during the Spanish Flu. However, there is limited research testing
human subjects on the effectiveness of facemasks in preventing influenza transfer or
transmission. The objective of this study was to answer the question, “In influenzapositive Veterans, what is the effect of facemask wearing in comparison to not wearing a
facemask on influenza transfer to bedside tables measured for two hours per condition
over a ten-week time frame during the 2019/2020 influenza season?” A quasiexperimental evidence-based project pilot study design was used. Influenza-positive
Veterans admitted to the Salem Veterans Affairs Medical Center were recruited to
participate in the study. Surface swabs were used to measure the presence of influenza on
bedside tables. Worn facemasks were also tested for influenza. A study questionnaire
collected qualitative information on tolerability and feasibility of wearing a facemask
when sick with influenza. Eight participants completed the study from January 2, 2020 to
March 11, 2020. No influenza was captured on any bedside table under either facemaskwearing condition. One hundred percent of participants claimed it was easy or very easy
to wear their facemask. Fifty percent of participants selected two hours as the time frame
they could tolerate wearing a mask; the other 25% specified they could wear their
facemask for three hours or five hours or more, respectively. This pilot study will guide
future research, and it affirmed wearing facemasks is a tolerable infection control practice
for providing source control.
Keywords: facemasks, source control, influenza
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Introduction
Wearing facemasks for source control is a controversial topic of late because of
the worldwide spread of the novel coronavirus of 2019/2020. Despite this pandemic,
influenza has remained a threat to humanity. According to the World Health Organization
(WHO), influenza results in 250,000 to 500,000 deaths annually worldwide (Federici et
al., 2018). Nosocomial transmission of influenza is a cause of morbidity and mortality
among patients; regrettably, 17% of the cases are acquired in a healthcare setting
(Ridgway et al., 2015). Healthcare workers can serve as vectors for influenza and may
shed it before the onset of symptoms (Talbot & Schaffer, 2010). However, symptomatic
patients can also transmit influenza to healthcare workers who in turn take it home and
risk the well-being of their families (Radonovich et al., 2009). Furthermore, the cost of
influenza puts a strain on healthcare systems. In 2003, the direct costs of influenza
treatment were $10.4 billion in the United States alone. Influenza also puts a burden on
direct health-related out-of-pocket expenditures and indirect costs related to productivity
loss due to worker absenteeism (Federici et al., 2018).
Presently, there is limited research revolving around reducing influenza transfer
or transmission using facemasks for source control. Source control is defined as “the
process of containing an infectious agent either at the portal of exit from the body or
within a confined space” (Siegel et al., 2007, p. 137). Current guidance to prevent
influenza transmission is focused on influenza prevention (through vaccination) rather
than on reducing the spread of influenza by symptomatic individuals. Unfortunately, the
annual influenza vaccine only reduces the risk of influenza 40% to 60% when the
circulating influenza viruses match those found in the vaccine (Centers for Disease
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Control and Prevention [CDC], 2018c). In the event of an influenza pandemic, antiviral
medications and vaccines may be in short supply; therefore, attention should be given to
nonpharmaceutical interventions, such as facemasks, to contain the virus (Aiello et al.,
2012).
Background
Respiratory hygiene and cough etiquette are widely encouraged infection control
practices to serve as means for source control against influenza (Skaria & Smaldone,
2014). Current standards of care require symptomatic patients with influenza-like illness
(ILI) to don a facemask upon entering the hospital (CDC, 2018b). Once admitted, they
are only asked to don masks when leaving their rooms, while healthcare personnel are
required to wear facemasks instead in patients’ rooms. Droplet precautions are also
initiated for laboratory-confirmed influenza (CDC, 2018b). The purpose of these
transmission-based precautions is to protect healthcare personnel from acquiring
influenza.
Coughing and sneezing often generates an expiratory spray containing influenza
particles ranging in size from <1 to 1,000 micrometers (μm), which is in part how
influenza transmission begins. During coughing, most particles are small with a
geometric mean diameter of 13.5μm. Larger droplets (>20μm) deposit in the mouth and
nose and can be inhaled, but they are too large to reach the lungs. Droplet nuclei
(aerosols) are typically <5μm and can be inhaled into the lower respiratory tract
(Killingley et al., 2016). Since influenza transmission is thought to be multimodal,
through contact, droplet, or airborne transmissions (Johnson et al., 2009), attention should
be given to contain the virus at the source.
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Problem Statement
Facemasks are donned by healthcare personnel to protect them from acquiring
respiratory illnesses. Facemasks reduce the risk of secretions and excretions from
reaching the mouths and noses of workers. However, facemasks do not have adequate
filtering or fit to provide respiratory protection (U.S. Food and Drug Administration
[FDA], 2018), which is why facemasks on the symptomatic individual (source control) is
a practice warranting more research. Placing a facemask on the source patient helps to
deflect viral shedding into the air or onto inanimate objects. Facemasks are defined as
loose-fitting, disposable devices that create a physical barrier between the nose and
mouth of the wearer and potential contaminants in their immediate environment.
Conversely, respirators such as N95s are designed to achieve a very close fit and efficient
filtration of airborne particles. While N95s filter 95% of particles from entering the nose
and mouth of wearers, facemasks do not (FDA, 2018). Thus, the current practice
recommended by the CDC (2018b) for healthcare personnel to don facemasks in the
presence of influenza-positive inpatients may not protect them from influenza
transmission.
The Salem Veterans Affairs Medical Center (Salem VAMC) in Salem, Virginia,
only recommends healthcare personnel (not symptomatic patients) to wear a facemask
when entering influenza-positive patient rooms. Since many of these patients will also
receive nebulizing treatments, facemasks will not protect the healthcare personnel from
the influenza droplet nuclei.

FACEMASKS FOR SOURCE CONTROL

4

PICOT and Research Question
The PICOT question, “In influenza-positive Veterans, what is the effect of
wearing a facemask in comparison to not wearing a facemask on influenza transfer to
bedside tables measured for two hours per condition over a ten-week time frame during
the 2019/2020 influenza season?” was tested. The research question, “What is the
outcome of placing an influenza-positive Veteran in a facemask in relation to comfort of
the mask and influenza transfer to hospital bedside tables?” was answered by the study
presented.
Conceptual Framework
The Translational framework for public health research was chosen to guide this
research. According to Mitchell et al. (2010), this framework is used to “emphasize the
effectiveness of interventions with widespread application and methods to make target
audiences aware of, receive, accept, and use information/interventions” (p. 291). Simply
put, the effectiveness of donning facemasks on symptomatic individuals (intervention)
can be applied to a larger target audience to benefit the masses with a focus on improving
the use of facemasks to promote public health by reducing influenza transmission. Public
health is defined as “the science and art of preventing disease, prolonging life, and
promoting health through organized efforts of society” (Ogilvie et al., 2009, p. 3). The
framework uses surveillance data to drive change through implementation while
considering the basic sciences, modifiable factors, possible interventions, and
intervention studies. Once the intervention is applied or the intervention study is
complete, the evidence synthesis process begins by using the knowledge gleaned to
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directly affect professional practice and indirectly reform health policy (Ogilvie et al.,
2009). Appendix A provides a visual to illustrate the structure of this framework.
Literature Review
Available Knowledge
Literature to determine if donning a facemask is effective for source control
against influenza is scarce. However, systematic reviews by Jefferson et al. (2008; 2011)
analyzed literature on physical interventions used to prevent the spread of respiratory
viruses. Their conclusions were providing physical barriers such as wearing a mask,
handwashing, and isolation of potentially infected patients were effective and low-cost
interventions in preventing the spread of respiratory viruses (Jefferson et al., 2008; 2011).
Another systematic review by bin-Reza et al. (2011) concluded their literature search did
not establish a conclusive relationship between facemask/respirator use and protection
against influenza. Since existing systematic reviews on the top are inconclusive, a
literature review was completed to thoroughly analyze the articles available studying the
effects of facemasks for source control and facemask efficacy and effectiveness, in varied
environments, and under different mask-wearing conditions.
Search Strategy
An integrated review of literature on facemasks for source control against
influenza was conducted using the databases PubMed, Scopus, and CINAHL. Full text,
English language articles from 2008 through 2018 were filters used for PubMed using the
keywords “masks and influenza,” “surgical mask and influenza,” “masks and source
control,” and “disease transmission and influenza.” Literature published after 2018 is
focused on facemasks and coronavirus, so dates beyond December of 2018 were not used
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in the search. Key terms used for Scopus included “facemasks and influenza,” “disease
transmission and influenza,” “masks and influenza and healthcare,” and “surgical masks
and exposure.” Key terms used for CINAHL included “facemasks and influenza,”
“facemasks and influenza and healthcare workers,” “surgical masks and source control,”
and “surgical masks and source control and healthcare.” In total, 1,012 articles resulted
from these databases and key terms.
Inclusion/Exclusion Criteria
The selection process for this literature review included determining inclusion and
exclusion criteria. After reviewing article titles, inappropriate or duplicate finds were
excluded. Other excluded articles included qualitative studies or research testing for other
illness transmission besides influenza. Articles about the challenges of, and reasons for,
influenza transmission were also excluded, since they were not relevant to the topic of
facemasks for source control. Similarly, studies testing for efficacy of N95s/respirators,
and studies done in the operating room, as well as studies involving children or
community settings, were also excluded. Pertinent articles involving household
transmission of influenza were included because very few studies done in healthcare
settings were identified. Other articles included in the literature review were studies
testing influenza transmission and surrogate studies testing for facemask efficacy. Over
60 articles were retrieved and read for content. Twelve articles met inclusion criteria.
Target Population/Eligibility Criteria
To be eligible for the human subject studies by Milton et al. (2013) and Johnson
et al. (2009), participants had to test positive for both rapid influenza and polymerase
chain reaction (PCR) tests. To be eligible for the Aiello et al. (2010; 2012) studies,
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participants had to be at least 18 years old and agree to use hand sanitizer, wear a
facemask, and complete baseline and weekly surveys for the duration of the six-week
study. If they became ill, they had to agree to have a throat swab specimen obtained.
Participants in the MacIntyre et al. (2016) study had to be 18 years or older with ILI who
attended a fever outpatient clinic in Beijing during the study period.
In the Cowling et al. (2009) study, participants with at least two symptoms of
acute respiratory illness (symptom onset within 48 hours) were recruited from 45 Hong
Kong clinics. Participants in both studies had to live in a household with at least two
others and could not have been exposed to ILI in the household 14 days prior to the start
of the study. Loeb et al. (2009) required enrolled nurses to work in medical units,
emergency departments, and pediatric units in one of the eight Ontario hospitals they
used for their research. Nurses had to work full-time (>37 hours per week) and provide a
current fit-test certification.
The surrogate studies did not use participants but rather different facemasks or
N95s placed on manikins to test their hypotheses. Diaz and Smaldone (2010), Booth et al.
(2013), Mansour and Smaldone (2013), Lai et al. (2012), and Patel et al. (2016)
conducted studies using radiolabeled wet aerosols (or influenza) to test particle counts in
the mouths of the receiver manikins. The source and receiver manikins simulated tidal
breathing within three feet to mimic human interaction. The source manikin in the Patel
et al. (2016) study also simulated coughing and sneezing to test how the velocity of wet
aerosols affected transmission to the receiver.
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Literature Review Discussion
When facemasks were placed on the source, better protection was provided
against particulate (or influenza) transmission than when a mask was donned on the
receiver. The surrogate studies concluded distance, velocity of transmission, ventilation,
as well as mask-fit influenced particulate transmission to the receiver more than the
facemask type. For example, compared to the previous study by Diaz and Smaldone,
(2010), the research by Mansour and Smaldone (2013) yielded higher simulated
workplace protection factor values indicating the masks had a better fit (and provided
better protection) with the softer Resusci Anne CPR manikin head than the “Brad”
manikin with a hard, nondeformable face. The reliability of the surrogate studies was
evaluated by how many times the experiment was run; more experimental trials ensured
accuracy of the study results. Lai et al. (2012) ran experimental trials 20-30 times. Patel
et al. (2016), Booth et al. (2013), and Mansour and Smaldone (2013) only ran three
experiments under each condition and/or environment. Diaz and Smaldone (2010) ran
each experiment three to nine times.
In the true source control studies using human subjects, Milton et al. (2013) and
Johnson et al. (2009) recruited small sample sizes (37 and nine, respectively) from the
University of Massachusetts and an emergency department in Austin, Texas. If these
studies had more participants from various locations/settings, the quality of the studies
would improve because they would be more generalizable to the overall population and
prevent homogeneity within the study sample. Participants were tested with two different
influenza tests prior to the intervention in both studies. These influenza tests ensured
reliability of the study samples.
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The results of the Johnson et al. (2009) study were conclusive. Facemasks
prevented influenza virus from reaching transport mediums on Petri dishes placed eight
inches in front of influenza-positive subjects. Subjects were asked to cough donning a
facemask, as well as a N95. The outcome was that there was no detectable transfer of
influenza from subjects to transport medium while using the facemask or N95. Results of
the Milton et al. (2013) study yielded a 3.4-fold reduction (95% confidence interval 1.8 to
6.3, p = .01) of influenza virus aerosol shedding of coarse and fine fractions into an air
sampler when facemasks were used for source control.
In the other studies using human subjects by Cowling et al. (2009), Loeb et al.
(2009), MacIntyre et al. (2016), and Aiello et al. (2010; 2012), adherence to maskwearing could not be assessed for all participants and interactions. Additionally,
influenza exposure outside of designated study areas could not be avoided; however, the
sample populations were randomized, so the exposures to influenza were thought to be
well balanced within the studies. Aiello et al. (2010; 2012) determined their studies were
underpowered to detect low reductions in the rates of ILI and because information on ILI
was self-reported, reporting bias may have been a factor threatening the internal validity
of their studies. Additionally, given the limited age range and specialized living
conditions of the sample, the study results were not generalizable to other community
dwelling populations.
All 12 studies used appropriate, high-quality study designs with levels of evidence
rated level II or III. The surrogate studies were evaluated as level III level of evidence.
Also, five of the 12 studies were randomized controlled trials, which are considered the
strongest research design with an intervention (Lewis, 2017). The reliability and validity
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of the instruments reviewed in all the studies included in this literature review were not
discussed by the authors. However, PCR testing was used in most of the studies to detect
influenza transmission, which is considered a rapid and sensitive method for detection of
influenza (WHO, 2017). Calibration of the instruments used in the surrogate studies was
mentioned. Calibration checks for accuracy of measuring instruments (Brei, 2013).
Therefore, calibration ensures reliability of the instruments used.
Of the 12 articles reviewed for this literature review, seven studies tested
facemasks for source control. One study by Cowling et al. (2009) requested healthy and
symptomatic individuals to don facemasks. Four studies tested facemask effectiveness or
efficacy by determining influenza transmission rates when healthy individuals or the
receiver manikin donned masks (Aiello et al., 2010, 2012; Loeb et al., 2009; Booth et al.,
2013). The study by Lai et al. (2012) required the receiver manikin to don a facemask
under different wearing and experimental conditions to determine the protection degree
provided by the facemask.
Literature Review Conclusions
Five studies used manikins to test their hypotheses, in part because human subject
testing requires more stringent guidelines and may put participants at risk for harm
(influenza transmission). When facemasks were placed on the source patient, the receiver
was better protected against influenza transmission based on the available studies
included in this literature review. All the articles showed varying levels of protection
against the spread of influenza when a facemask was donned by the symptomatic or
healthy individual. Based on this extensive review, a study was not found testing
influenza viral shedding onto inanimate objects in a hospital setting under different
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facemask-wearing conditions, which inspired development of this study protocol. Placing
a facemask on the source patient should decrease influenza transmission to healthcare
personnel, and influenza transfer onto inanimate objects, providing more protection from
influenza.
Study Aims
The aim of this research was to test if facemasks serve as effective means for
source control. The secondary aim was to collect qualitative data on the tolerability and
feasibility of wearing a facemask when one is sick with influenza.
Methods
This quasi-experimental evidence-based project pilot study examined the
feasibility of a research approach to guide the future design and implementation of a
larger scale study. Matters such as recruitment, intervention implementation, and
retention (Leon et al., 2011) were examined by this pilot study. This research also
collected qualitative and quantitative information. Qualitative information was collected
through a study questionnaire used to determine tolerability and feasibility of wearing a
facemask when an individual was sick with influenza. Quantitative information was
collected by swabbing bedside tables for influenza to compare the amount of virus
captured after wearing a facemask and then after not wearing a facemask.
Setting
The setting used was the Salem VAMC in Salem, Virginia, on two
medical/surgical floors. No participants were recruited from the progressive care unit or
the community living center floors. Veterans admitted to the intensive care unit (ICU)
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were determined to be too sick to participate in this pilot study, so Veterans admitted to
this unit were not asked to participate.
Ethical Considerations
The appropriate steps for conducting human subject research was carried out prior
to the start of the study. Institutional review board approval was granted by the Salem
VAMC in November of 2019 and by James Madison University in December of 2019.
Obtaining written consent from influenza-positive Veterans was not required since the
research was approved as a quality improvement project. Participants were informed that
they could decline from participation from the study at any time.
The research was conducted during the 2019/2020 influenza season and extended
from January 2, 2020 through March 11, 2020. The goal was to collect samples from 12
influenza-positive Veterans’ bedside tables during the specified time frame. This goal
was established based on reviewing historical data on the number of influenza-positive
Veterans admitted to the Salem VAMC from two years prior. In total, eight influenzapositive Veterans met inclusion criteria and successfully completed the study. Inclusion
criteria included participants had to be laboratory-confirmed for influenza during the
2019/2020 influenza season and inpatients at the Salem VAMC, with a symptom onset of
illness < 120 hours.
Influenza-positive (laboratory-confirmed rapid, immunoassay) Veterans were
identified through Theradoc, the Salem VAMC’s surveillance reporting software system.
From January to March 2020, positive influenza results were reviewed to determine if the
individual with influenza was admitted to the Salem VAMC. If admitted, one of two subprincipal investigators approached the Veteran to ask if they wanted to participate in the
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study. The study details and requirements were presented to the Veterans and all verbally
agreed to participate prior to starting. The steps explaining the intervention and data
collection process are listed below.
1) A full set of vital signs was obtained and documented to ensure each
participant was not hypoxic prior to placing a facemask on them.
Veterans with an oxygen saturation less than 90% on room air were
not to be asked to participate in the study. None of the recruited
participants were hypoxic on the date of their participation.
2) If the participant agreed, a nasopharyngeal swab was collected to
determine the number of viral influenza copies present on the day of
the study.
3) Veterans were asked to wash their hands and arms and change their
shirt or hospital gown prior to starting the facemask-wearing
intervention.
4) Education was provided to participants on how to properly don a
facemask to ensure they felt comfortable and confident with placement
of the mask on their face. Facemasks were carefully placed on the
influenza-positive Veteran by a sub-principal investigator, making sure
to cover the Veteran’s nose and mouth. The Precept® FluidGard® 160
Procedure Mask 15300, Precept Medical Products, Inc., Arden, NC
was worn by all participants.
5) It was explained to the Veteran that when the study was underway,
they would need to agree to stay in place with the bedside table over
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their bed/chair and located no more than three feet from their mouths.
To prevent cross-contamination to the bedside table, they were asked
to keep drinks, cell phones, and other items off the bedside table. A
small baggie, tissues for nose blowing, and hand sanitizer were placed
near the Veteran, so they did not contaminate the bedside table by
putting used tissues or their contaminated hands on the bedside table.
A short questionnaire was presented to the Veteran to fill out during
the study. The questionnaire asked if the Veteran removed their
facemask for any reason during the first 30 minutes, second 30
minutes, etc. during the study. The questionnaire provided options to
check off like, “facemask removed to blow nose.” The questionnaire
also asked questions like “in the first 30 minutes, did you cough or
sneeze?” See Appendix B for the study questionnaire.
6) The bedside table was swabbed in four locations (after cleaning it with
CaviWipe1 and sterile water) before the Veteran donned a facemask
for two hours. This process ensured the bedside table was clean prior
to starting the study.
7) The bedside table was swabbed in four locations again after the
Veteran wore the facemask for two hours.
8) The Veteran was given a short break.
9) The bedside table was swabbed in four locations (after cleaning it with
CaviWipe1 and sterile water) before the Veteran began two hours of
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not wearing a facemask. The Veteran was reminded to stay in the
bed/chair with the bedside table over them during these two hours.
10) After two hours, the bedside table was swabbed in four locations for
the last time. The bedside table was cleaned and returned to the
Veteran. The Veteran was told that the study had concluded, and
contact information was provided to them in case they had questions.
11) The study questionnaire was collected.
Collected swabs were placed in a transport medium vial containing three
milliliters of Hanks’ Balanced Salt Solution (Thermo Fisher Scientific) supplemented
with 0.1% bovine serum albumin (BSA; Sigma-Aldrich, St. Louis, MO,) and 100
units/mL penicillin G and100 units/mL streptomycin (Thermo Fisher Scientific). Vials
were appropriately labeled and stored in a freezer at the Salem VAMC at -70oC until they
were ready to be shipped on dry ice to the CDC/National Institute for Occupational
Safety and Health (NIOSH) in Morgantown, West Virginia, for testing. Worn facemasks
were also labeled and stored in a freezer at the Salem VAMC at -70oC.
The CDC/NIOSH tested for influenza A and B from the samples and facemasks.
A real-time PCR assay was used to detect the virus genome from the samples. Real-time
reverse transcription PCR testing is considered a rapid and sensitive method testing for
influenza and it is the first-choice laboratory test for detecting influenza viruses with
pandemic potential (WHO, 2017). The sensitivity of this instrument ensured the
reliability and validity of the study.
Swabs used for influenza testing were sterile and made of nylon (Copan
FLOQSwabsTM, Murrieta, CA). They were moistened with a viral transport medium and
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rubbed across an area of approximately 100cm2 in three different directions, applying
even pressure. Two swabs were obtained each time the bedside table was swabbed in four
different locations on the table. The first swab was moistened each time before placing it
to the bedside table, the second swab was dry, and it was rubbed in all three directions
until most of the transport medium was absorbed.
According to the CDC (2018a), individuals with influenza are most contagious on
days three and four of illness onset, which is why every attempt was made to conduct the
research on these days. Sub-principal investigators obtained demographic information on
each participant and documented the day of illness onset, for comparison. Demographic
information obtained included their age, gender, admitting diagnosis, influenza type, and
other pertinent medical information like whether they were asthmatic, had a fever on the
day of testing, or had received the influenza vaccine in the same influenza season. Also
documented was whether participants had received the antiviral, Tamiflu, and the number
of doses they received prior to the start of the study. Healthcare personnel continued to
wear appropriate personal protective equipment (PPE) when entering the room of
Veterans enrolled in the study; therefore, their practice did not change.
The data collection tool, the questionnaire, collected non-compliance of the
facemask-wearing condition, if it was reported. However, a sub-principal investigator
was monitoring the study participants for facemask adherence most of the time. The subprincipal investigator asked each participant if they had questions about or needed help
completing the questionnaire before and after the study to ensure accuracy of the
reporting.
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Results
Eight Veterans with laboratory-confirmed influenza participated in this study
from January 2, 2020 through March 11, 2020. Pertinent participant information is
displayed in Appendices C-E. Six participants had influenza A and two had influenza B.
All participants had two or more symptoms of influenza such as cough, chills, malaise,
sore throat, shortness of breath, fatigue, weakness, rhinitis, myalgia, diarrhea, and/or
headache.
Demographic information such as age and gender are displayed in Appendix C in
a way that no one participant could be identified. Clinical information about the
participants is displayed in Appendix D. Seventy-five percent of participants were over
65, 50% had diabetes, and 37.5% smoked cigarettes. Fifty percent of the participants
received influenza vaccination, and all received at least one dose of Tamiflu prior to the
start of the study.
Neither influenza A nor B was detectable by qPCR on bedside tables for any of
the eight participants under either facemask-wearing condition. However, three of the
participants’ surface samples were not analyzed because either their worn facemask or
nasopharyngeal swab did not test positive for influenza. One participant refused a
nasopharyngeal swab, so his surface samples were not analyzed. Results are displayed in
Appendix F.
Collected samples were analyzed by qPCR for the matrix (M1) gene using the
following primers and probe for influenza B: +24F: 5’TGCCTACCTGCTTTMMYTRA
CA 3’, -98REV: 5’CCRAACCAACARTGTAATTTTTCTG 3’, and +51PRB: 5’VICTGCTTGCCTTCTCCA-MGBNFQ 3’. The matrix primers and probe for influenza A
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were +25F: 5’AGATGAGTCTTCTAACCGAGGTCG 3’, -124REV: 5’TGCAAA
AACATCTTCAAGTCT CTG 3’, and +64PRB: 5’6FAM-TCAGGCCCCCTCAAA
GCCGA-MGBNFQ 3’.
Qualitative information such as the number of hours participants tolerated the
facemask- wearing condition, as well as general experiences and opinions about ease or
difficulty wearing the facemask are displayed in Appendix E. One hundred percent of
participants thought it was easy or very easy to wear the facemask. Twenty-five percent
of participants reported they felt no discomfort wearing the facemask, while 12.5%
experienced shortness of breath, 37.5% felt general discomfort, and 62.5% reported
warmth while wearing the mask. The questionnaire listed one hour, two hours, three
hours, four hours, and five or more hours as options for the time frame one could tolerate
wearing the facemask. Fifty percent picked two hours as the longest time frame they
could tolerate wearing the facemask. Twenty-five percent of participants selected they
could wear the facemask for three hours or five hours or more, respectively.
Discussion
Facemasks are currently donned by healthcare workers and not inpatients sick
with influenza while in their hospital rooms. This puts healthcare workers at risk for
getting influenza since facemasks may not protect them from small droplets of influenza.
Our study recruited eight influenza-positive Veterans who were inpatients at the Salem
VAMC during the 2019/2020 influenza season. Veterans were asked to wear a facemask
and report their experiences with wearing a mask during the facemask-wearing
intervention. While it was not expected to capture no influenza on any of the bedside
tables during the no facemask-wearing condition; it was affirming no influenza was

FACEMASKS FOR SOURCE CONTROL

19

captured after the facemask-wearing intervention. The study questionnaire also answered
collected data about feasibility and tolerability of wearing a facemask when individuals
were sick with influenza. All participants stated it was easy or very easy to wear the
mask, while 62.5% expressed general discomfort, such as warmth from wearing the
facemask.
Our findings were similar to other studies whose aim was to capture influenza on
fomites. Ahrenholz et al. (2018) captured influenza on two surface samples out of the 483
tested. Killingley et al. (2016) captured influenza on 33 surface samples out of the 671
tested. Our study tested 80 surface samples (40 pre intervention, 40 post intervention) of
the 128 collected. When influenza was not detected on a participant’s facemask or their
nasopharyngeal swab, no surface samples were analyzed.
Wearing facemasks for source control fits into the theoretical model,
Translational framework for public health research, as an intervention that serves to
improve the health of the general public. The implications for practice from the results of
this research are limited since the sample population was small and no influenza was
captured on bedside tables from either testing condition. However, since all participants
found wearing the facemask to be easy and tolerable for two to five hours or more, this
suggests requesting influenza-positive individuals to don facemasks while healthcare
workers are in their rooms is a feasible recommendation. More research on facemasks for
source control is warranted to justify the benefit of facemasks in preventing influenza
transfer to fomites. Future research will further shape education and policy development.
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Limitations
Potential limitations of this study included (1) one recruitment location, (2)
Veterans participating in the study had different days of illness onset or may have
inaccurately reported their day of illness onset, and (3) testing was completed during a
single influenza season. Other possible limitations are the questionnaire was obtained via
self-reported data (as well as monitor observation), which may have introduced bias to
the study design. Additionally, some participants moved the bedside table more than
three feet from their mouths at times and all received one or more doses of Tamiflu.
Lastly, since the sample size was small (N=8) and convenience sampling was used to
recruit participants, results may not be generalizable to the overall population.
Strengths
Our study had several strengths. First, all participants were laboratory-confirmed
by rapid influenza immunoassay. Sub-principal investigators served as monitors during
the intervention arms to ensure facemask adherence by the participants. Worn facemasks
were tested for influenza presence, which confirmed viral shedding and deflection into
the mask. Finally, the instrument used for testing, PCR, is considered a rapid and
sensitive method for detecting influenza viruses.
Conclusions
This pilot study affirmed facemasks used for source control prevented influenza
transfer to bedside tables under the facemask-wearing condition, yet no influenza was
detected when participants did not wear their facemasks as well. Therefore, the outcome
of this research was inconclusive since there was no difference between influenza transfer
to bedside tables whether a facemask was worn or not. Facemasks were considered easy
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to wear, and the participants tolerated wearing masks for two hours or more when sick
with influenza. However, several Veterans reported feeling general discomfort, namely
warmth when wearing their facemask. Wearing facemasks is a cost-effective and
sustainable practice within hospital settings. Therefore, it may be beneficial to suggest
changing policies to require that patients sick with influenza or other respiratory illnesses
begin this practice based on the momentum established by infection control measures
initiated during the coronavirus pandemic of 2019/2020.
While many strengths were identified, additional research on facemasks for
source control will benefit from what was learned from this study to improve future study
designs. Placing the bedside table closer, two feet instead of three, from participants’
mouths may increase the chances of influenza viruses landing on the surfaces used for
testing. Additionally, increasing the number of locations swabbed on bedside tables will
increase the chances of influenza capture. Consideration should also be given to
determine how the bedside tables will be cleaned to prevent extended kill times from
potentially preventing influenza capture. Lastly, a larger study would provide greater
statistical power to identify the effects of facemasks for source control on transfer of
influenza to bedside tables. Future research on the topic of facemasks for source control
against respiratory illnesses, including influenza and coronavirus, will benefit the
scientific community and humanity at large.
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Translational Framework for Public Health Research
Figure 1.
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Appendix B
Study Questionnaire
Figure 2. Please put a check mark or x on the appropriate circle for questions 1-12.
Date

Time

DOB

Last four

Subject Name

1. During
the first 30
minutes of
the study
did you
cough or
sneeze?

o YES

o NO

2. During the first
30 minutes of the
study did you
remove your
facemask or leave
the bed/chair for
any reason?

o YES

3. During
the second
30 minutes
of the study
did you
cough or
sneeze?

o coughed
o sneezed
o both

o YES

o NO

o coughed
o sneezed
o both

4. During the
second 30 minutes
of the study did you
remove your
facemask or leave
the bed/chair for
any reason?

o NO

o to blow my
nose
o shortness of
breath
o some other
reason
Explain here:
o YES

o NO

o to blow my
nose
o shortness of
breath
o some other
reason
Explain here:

5. During
the third 30
minutes of
the study
did you
cough or
sneeze?

o YES

o NO

o coughed
o sneezed
o both

6. During the third
30 minutes of the
study did you
remove your
facemask or leave
the bed/chair for
any reason?

o YES

o NO

o to blow my
nose
o shortness of
breath
o some other
reason
Explain here:

7. During
the fourth
30 minutes

o YES
o coughed

o NO

8. During the fourth
30 minutes of the
study did you

o YES

o NO
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of the study
did you
cough or
sneeze?

o sneezed
o both

remove your
facemask or leave
the bed/chair for
any reason?
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o to blow my
nose
o shortness of
breath
o some other
reason
Explain here:

9. During
the study
did you
experience
any of the
following
due to
wearing the
facemask?

o I felt
o NO
general
discomfort
.
o I felt
warm or
hot.
o I felt
sweaty.
o I felt
short of
breath.
o I got a
headache.

10. Could
you tolerate
wearing the
facemask
for two
hours?
11. If you
were asked
to wear the
facemask
again, how
easy would
it be for you
to do so?

o YES

Other comments?

Why?

o NO

o Very
easy
o Not so
easy
o Difficult
o Very
difficult

Other comments?

Why not?
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12. How
long do you
think you
could
tolerate
wearing a
facemask?

o One
hour
o Two
hours
o Three
hours
o Four
hours
o Five
hours
o More
than five
hours

Other comments?
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Appendix C
Participants’ Demographic Information, Influenza Virus Type, Illness Onset Day,
and Influenza Vaccine/Cigarette Use Status
Table 1.
Male
Aged >65
Influenza A
Illness Onset Day 2 or 3

N=8
8
6
6
4

Percent
100
75
75
50

Illness Onset Day 4

4

50

Influenza Vaccine Recipient

4

50

Cigarette Use

3

37.5
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Appendix D
Participant Temperatures, Antiviral Administration (in Doses), and Pertinent
Medical Information
Table 2.
Participant

1
2
3
4
5
6
7
8

Tmax on
study date
> 37.8oC

No
No
No
No
No
No
No
Yes

Antiviral (#
of doses
received
prior to
study)
2
2
2
2
2
2
4
1

Pertinent
Diabetes
medical
history (PNA
or COPD)

Asthma

Yes
No
No
No
Yes
Yes
No
No

No
No
No
No
No
No
No
No

Yes
No
Yes
Yes
Yes
No
No
No
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Appendix E
Number of Hours Tolerated Facemask-Wearing Condition, General
Experiences Wearing Facemask, and Opinion About Ease or Difficulty Wearing
the Facemask
Table 3.
Two hours
Three hours
Five hours or more
Warmth
General discomfort
Shortness of breath
No discomfort
Easy or Very Easy

N=8
4
2
2
5
3
1
2
8

Percent
50
25
25
62.5
37.5
12.5
25
100

FACEMASKS FOR SOURCE CONTROL

29

Appendix F
Influenza A or B Detection on Nasopharyngeal Swabs, Masks, and Bedside Tables
Table 4.
N=8
Nasopharyngea
l
swab (total M1
copies in
sample)
1
DNQ*
2
2.40E+03
3
46.0
4
UD
5
2.94E+03
6
no sample
7
2.64E+02
8
UD

Worn
mask

Before
mask
interventio
n

After
mask
interventio
n

Before
unmasked
interventi
on

After
unmasked
interventio
n

UD
DNQ
UD
NA
DNQ
DNQ
UD
UD

UD
UD
UD
NA
UD
NA
UD
NA

UD
UD
UD
NA
UD
NA
UD
NA

UD
UD
UD
NA
UD
NA
UD
NA

UD
UD
UD
NA
UD
NA
UD
NA

DNQ = detectable but not quantifiable
*denotes influenza B
UD = undetected
NA = not assayed
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